BRCA1 and ovarian cancer: Abkevich and colleagues discovered that LOH of intermediate lengths (>15 Mb, but less than the entire chromosome) were significantly associated with HRD, defined as a deficiency in BRCA1/2 (p = 10−11) or RAD51C (p = 0.0003), in ovarian cancer [8].